The stable transfectants of wild-type (W25) and mutant thyrotropin-receptor (TSH-R) 
INTRODUCTION
(TSAb) as well as blocking (TBAb) (11, 12, 14) .
Mcl+2 was transfected with a chimeric receptor construct, where residents 8 to 165 of the human TSHR extracellu¬ lar region were replaced with residues 10 to 166 of the LH-CGR (11, 12, 14 (Fig. 1A) , confirming previous results (11, 14 (11, 12, 14 Increasing evidence indicates that the stimulating TSHRAb is heterogeneous (25, 26) . Morever, measuring this heterogeneity of TSAbs has potentially identified a subtype of TSAb with clinical implications, ie, respon¬ siveness to medical (antithyroid drugs) therapy (13 
